- On August 31, the value of Bitcoin had a significant decrease, exhibiting a dip of more than 4.5% and descending below the threshold of $26,000.
- The decrease in price occurred subsequent to a judicial decision concerning Grayscale, resulting in the elimination of the previously accumulated profits during the earlier part of the week.
- The United States Securities and Exchange Commission (SEC) has recently disclosed a postponement in the approval process for seven spot Bitcoin exchange-traded fund (ETF) applications. These applications are submitted by prominent entities like as BlackRock, VanEck, and Valkyrie.
- The appreciation of the United States Dollar also exerted selling pressure on diverse financial assets.
- The Personal Consumption Expenditures (PCE) Index has indicated the presence of enduring elevated levels of inflation, which has had an impact on the performance of stocks.
- The S&P and Dow indices concluded the trading session with declines of 0.16% and 0.48% correspondingly, but the Nasdaq index registered a marginal increase of 0.11%.
- Analysts are engaged in speculation over the potential approval timeline of the inaugural spot Bitcoin Exchange-Traded Fund (ETF) by the Securities and Exchange Commission (SEC) in the United States. Following Grayscale’s recent legal triumph, a sense of optimism has emerged, leading to an estimation of a 75% likelihood of SEC approval by the conclusion of the year 2023.
- According to certain analysts, such as MichaΓ«l van de Poppe, there exists a greater likelihood of the Securities and Exchange Commission (SEC) granting permission for a Bitcoin Exchange-Traded Fund (ETF) application in either October or December. Additionally, there is speculation that the SEC will approve Ethereum ETF Futures in October.
- During the current market correction, Bitcoin experienced substantial liquidations, resulting in a decline in Open Interest to its former levels.
- According to the article, it is suggested that the decline in Bitcoin’s price might perhaps result in a further adjustment towards the range of $24,000-25,000, accompanied by an anticipated examination of the 200-week Exponential Moving Average (EMA).
(1)